2024 | Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007-2021: a nationwide, multicentre, retrospective cohort study
| ECLINICALMEDICINE |
2024 | Fibrotic Burden in Patients With Hepatitis B Virus-Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes | JOURNAL OF INFECTIOUS DISEASES |
2023 | Risk of dementia in the elderly with non-alcoholic fatty liver disease: A nested case-control study in the Republic of Korea
| Annals of the Academy of Medicine, Singapore |
2023 | Loss of Krüppel-like factor-10 facilitates the development of chemical-induced liver cancer in mice
| MOLECULAR MEDICINE |
2023 | Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2023 | A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | JOURNAL OF HEPATOLOGY |
2023 | The care cascade for hepatitis C virus and prognosis of chronic hepatitis C patients treated with antiviral agents in a tertiary hospital
| BMC GASTROENTEROLOGY |
2023 | Baseline and on-treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals | JOURNAL OF VIRAL HEPATITIS |
2023 | Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
| DIAGNOSTICS |
2022 | Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B | LIVER INTERNATIONAL |
2022 | MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups | DIGESTIVE DISEASES AND SCIENCES |
2022 | Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
| GUT AND LIVER |
2022 | Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
2022 | Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case report
| Journal of Liver Cancer(대한간암학회지) |
2022 | Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance
| DIGESTIVE DISEASES AND SCIENCES |
2021 | Telbivudine Plus Adefovir Versus Lamivudine Plus Adefovir for Lamivudine-Resistant Chronic Hepatitis B: TeSLA Randomized Trial
| HEPATITIS MONTHLY |
2021 | Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
2021 | Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
| CANCERS |
2021 | Pharmacokinetics and safety of evogliptin in hepatically impaired patients | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
2021 | Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2021 | Optimal indications and limitations of endoscopic transorbital superior eyelid surgery for spheno-orbital meningiomas | JOURNAL OF NEUROSURGERY |
2021 | Addition of liver stiffness enhances the predictive accuracy of the PAGE-B model for hepatitis B-related hepatocellular carcinoma | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2021 | Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study | DIGESTIVE DISEASES AND SCIENCES |
2021 | Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease: A Nationwide Nested Case-Control Study | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2020 | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir | JOURNAL OF VIRAL HEPATITIS |
2020 | A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2020 | Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2020 | Phase I Radiation Dose-Escalation Study to Investigate the Dose-Limiting Toxicity of Concurrent Intra-Arterial Chemotherapy for Unresectable Hepatocellular Carcinoma
| CANCERS |
2020 | Effects of Pancreatic Enzyme Replacement Therapy on Body Weight and Nutritional Assessments After Pancreatoduodenectomy in a Randomized Trial | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Cumulative Incidence of Hepatocellular Carcinoma and Hepatitis B Surface Antigen Seroclearance After Nucleos(t) Ide Analogue-Induced Hepatitis B E Antigen Seroclearance
| BMC GASTROENTEROLOGY |
2019 | Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
| SCIENTIFIC REPORTS |
2019 | Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2019 | The impact of the sleep duration on NAFLD score in Korean middle-aged adults: a community-based cohort study | Sleep Medicine |
2019 | Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study | ONCOLOGIST |
2019 | Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
| World Journal of Gastroenterology |
2019 | Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
| Cancer Medicine |
2019 | Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis
| CANCERS |
2018 | Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice
| CELL COMMUNICATION AND SIGNALING |
2018 | Antiviral Therapy in Patients With Chronic Hepatitis C-related Hepatocellular Carcinoma Responding to Palliative Treatment | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2017 | Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
2017 | Current role of transient elastography in the management of chronic hepatitis B patients
| ULTRASONOGRAPHY |
2017 | Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study
| ONCOTARGET |
2017 | Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
| GUT AND LIVER |
2017 | Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C.
| VIROLOGY JOURNAL |
2017 | Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis
| CELL TRANSPLANTATION |
2017 | Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective study
| RADIATION ONCOLOGY |
2017 | Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis
| ONCOTARGET |
2016 | Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
| CLINICAL AND MOLECULAR HEPATOLOGY |
2016 | KASL clinical practice guidelines: management of chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
2016 | Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea
| MEDICINE |